Stay updated with breaking news from Catalyst Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analyst Andrew Fein of H.C. Wainwright has scored a 100% success rate on his views on Catalyst Pharmaceuticals (NASDAQ:CPRX) stock. Fein is an ex...
/PRNewswire/ -- BioFlorida's 25th Annual Conference united statewide leaders of Florida's life sciences industry representing biopharmaceutical, medical...
CORAL GABLES, Fla. (AP) _ Catalyst Pharmaceutical Partners Inc. (CPRX) on Tuesday...
Equities research analysts forecast that Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) will announce sales of $43.17 million for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for Catalyst Pharmaceuticals’ earnings. The highest sales estimate is $44.01 million and the lowest is $42.75 million. Catalyst Pharmaceuticals reported sales of $30.21 […]
Wall Street analysts expect that Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) will post sales of $43.64 million for the current quarter, Zacks Investment Research reports. Four analysts have issued estimates for Catalyst Pharmaceuticals’ earnings, with the highest sales estimate coming in at $44.70 million and the lowest estimate coming in at $42.75 million. Catalyst […]